Clinical Trial

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

Study acronym: AGILE-Echo
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 20, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Heart Failure and valvular heart disease are disproportionate problems in rural and remote Australia (RRA). Echocardiography is the best imaging investigation, and essential for management, but access to this essential test shows huge geographic variations, primarily because of dependence on expert acquisition. This trial seeks to demonstrate the effectiveness of artificial intelligence-based echocardiography for triage and management of patients with known or suspected heart disease in RRA.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-09-25; most recent amendment 2025-10-16.
Status change: Not Yet Recruiting → Recruiting 2023-03-01
Trial Details
NCT Number NCT05558605
Lead Sponsor Baker Heart and Diabetes Institute
Collaborators: Alice Springs Hospital, Princess Alexandra Hospital, Brisbane, Australia, Royal Perth Hospital, Ochre Health, Walgett Aboriginal Medical Services, Merriden Health Service, Royal Hobart Hospital, Quairading Medical Practice
Conditions Heart Failure, Valve Heart Disease
Enrollment 612 participants
Start Date 2023-02-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-10-20